| Patient | Richard Roundtree |
|---|---|
| Date of birth | 1942-07-09 |
| Identifiers | MRN HR-ML015-SYN-TD; SSN (made up) 000-15-8410 |
| Document date | 1993-10-20 |
| Author | Leon Carrington, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Review two weeks after left breast cancer surgery. [S]
Mr. Roundtree returns thirteen days after mastectomy with level I and II axillary dissection for left breast cancer. He went home the next day. The drain was removed on the eighth day, and the wound has healed without infection or fluid. He took acetaminophen for the first ten days and needs nothing now. He has numbness under the left arm, as he was warned, and some tightness when he lifts the arm, which is improving with the exercises. He has no arm swelling. The pathology shows a 1.6 cm grade 3 invasive ductal carcinoma with clear margins, and 2 of 15 lymph nodes involved, the largest 7 mm, with no spread through the node capsule: stage IIA (pT1c pN1a). He saw medical oncology four days ago. They advised doxorubicin and cyclophosphamide every three weeks for four cycles, then weekly paclitaxel for twelve weeks, about six months in all, starting in about two weeks, then tamoxifen for at least five years, and a radiation oncology review after chemotherapy. An echocardiogram is booked this week. The germline result is not back. He feels low at times and worries about losing his hair and about work, but he is sleeping and eating. [S]
| Element | Detail |
|---|---|
| Surgery | Mastectomy and axillary dissection thirteen days ago; drain out; wound healed |
| Pathology | pT1c pN1a, grade 3, margins clear; stage IIA |
| Arm | Numbness under the arm; tightness improving; no swelling |
| Plan from oncology | About six months of chemotherapy, then tamoxifen; radiation oncology review afterwards |
| Mood | Low at times; PHQ-9 score 6 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; appetite good |
| Integumentary | Negative | Wound healed; no redness or discharge |
| Musculoskeletal | Positive | Tightness at the end of left shoulder movement |
| Neurological | Positive | Numbness under the left arm |
| Cardiovascular | Negative | No chest pain, palpitations, or breathlessness on exertion |
| Psychiatric | Positive | Low at times; PHQ-9 score 6; no thoughts of self-harm |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a day | Two tablets every 6 hours as needed | Oral route | 1993-10-07 to 1993-10-17 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1993-10-20 | Body height | 188 | cm | S |
| 1993-10-20 | Body weight | 84.8 | kg | S |
| 1993-10-20 | Body mass index (BMI) [Ratio] | 24 | kg/m2 | S |
| 1993-10-20 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1993-10-20 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1993-10-20 | Heart rate | 76 | /min | S |
| 1993-10-20 | Respiratory rate | 14 | /min | S |
| 1993-10-20 | Body temperature | 36.7 | Cel | S |
| 1993-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1993-10-20 | Hemoglobin [Mass/volume] in Blood | 13.9 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1993-10-20 | Leukocytes [#/volume] in Blood by Automated count | 7 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1993-10-20 | Neutrophils [#/volume] in Blood by Automated count | 4.3 | 10*3/uL | 1.5-7.7 10*3/uL | Normal | S |
| 1993-10-20 | Platelets [#/volume] in Blood by Automated count | 281 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1993-10-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1993-10-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1988)/1.73 sq M | 93 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1993-10-20 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 21 | U/L | 7-55 U/L | Normal | S |
| 1993-10-20 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 1993-10-20 | Albumin [Mass/volume] in Serum or Plasma | 4.3 | g/dL | 3.5-5 g/dL | Normal | S |
| 1993-10-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S |
Vital signs recorded on 1993-10-20; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well |
| Chest wall | Left mastectomy scar healed; no seroma, redness, or nodule; drain site healed |
| Lymph nodes | Left axillary scar healed; no nodes on either side |
| Musculoskeletal | Left shoulder flexion 150 degrees and abduction 130 degrees |
| Neurological | Reduced light touch over the inner left upper arm and armpit; strength normal |
| Extremities | Upper arm circumference 33.5 cm on both sides, 15 cm below the shoulder tip; no swelling of the left hand or forearm |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Invasive ductal carcinoma of the left male breast, central (retroareolar) portion, presenting as a 1.5 cm firm, painless lump eccentric to the left nipple with a palpable left axillary node; core biopsy: grade 3, ER positive, PR positive, HER2 negative, with metastatic carcinoma in the node; clinical stage IIA (cT1c cN1 M0); synthetic modern detail linked to his publicly disclosed breast cancer | active | confirmed | C50.122 | S — Synthetic size, grade, receptor status, and stage; the left-sided lump, the operation, and the spread to lymph nodes are from his public account (D). |
| Estrogen receptor-positive status of the breast cancer | active | confirmed | Z17.0 | S — Synthetic receptor result; his tumor biology was not made public. |
| New firm, painless lump of about 1.5 cm just off the left nipple, with a palpable left axillary node; suspected breast cancer, imaging and core biopsy booked | resolved | confirmed | N63.42 | S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the left-sided lump is from his public account (D). |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Blood count before chemotherapy | Before cycle 1 and each cycle (oncology) | Completed today | Hemoglobin 13.9 g/dL, white cells 7.0, neutrophils 4.3, platelets 281 |
| Laboratory | Kidney and liver function before chemotherapy | Before cycle 1 (oncology) | Completed today | Creatinine 0.98 mg/dL, eGFR 93; ALT 21 U/L, bilirubin 0.6 mg/dL, albumin 4.3 g/dL |
| Imaging | Echocardiogram with ejection fraction before anthracycline | Baseline before doxorubicin | Ordered | Booked this week |
| Laboratory | Hepatitis B screening before chemotherapy | Before the first cycle | Due | To be drawn at the preventive visit next week |
| Laboratory | Germline multigene panel testing | Once, for every man with breast cancer | Ordered | Sent fifteen days ago; result not yet back |
| Examination | Wound and shoulder movement after axillary surgery | Each visit after surgery | Completed today | Healed; flexion 150 degrees, improving |
| Examination | Lymphedema assessment and risk-reduction counseling | Every visit after axillary surgery | Completed today | Upper arm circumference 33.5 cm on both sides; skin care, avoiding tight sleeves on the left arm, and early reporting of swelling taught |
| Examination | Baseline arm circumference missed before surgery | Once, before axillary surgery | Deferred | Not measured before the operation, a deviation from the protocol. Measured today at thirteen days, before any swelling, and equal on both sides; the right arm serves as the reference. No harm is evident, and future measurements will be compared with today's |
| Survey | Distress and depression screen (PHQ-9) | Each visit | Completed today | PHQ-9 score 6, mild; no thoughts of self-harm; peer support and counseling offered |
| Medication safety | Tamoxifen safety (clot symptoms, mood, hot flashes, sexual side effects, adherence) | Every visit once tamoxifen starts | Not indicated | Tamoxifen starts after chemotherapy |
| Imaging | Mammography | Yearly only for a breast treated by lumpectomy, or the other breast with a predisposing variant | Not indicated | No breast was treated by lumpectomy. Imaging of the other side is considered only with a predisposing variant, and the germline result is pending |
| Self-management | Physical activity | Every visit | Completed today | Walking daily; gym work for the legs; no heavy lifting with the left arm for another two weeks |
Goal progress:
Guideline basis: Hassett MJ, et al. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol 2020;38(16):1849-1863 (2020); NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025); Armenian SH, et al. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: ASCO Clinical Practice Guideline. J Clin Oncol 2017;35(8):893-911 (2017); Hwang JP, et al. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol 2020 (2020); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026)
Follow-up: Echocardiogram this week. Preventive visit next week. Chemotherapy in about two weeks with medical oncology. Primary care review during chemotherapy. Next scheduled visit 1993-10-27: periodic adult preventive visit before chemotherapy. [S]